vs
Burlington Stores, Inc.（BURL）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Burlington Stores, Inc.的季度营收约是Steris的1.8倍（$2.7B vs $1.5B），Steris净利率更高（12.9% vs 3.9%，领先9.0%），Steris同比增速更快（9.2% vs 7.1%），Steris自由现金流更多（$199.5M vs $-109.6M），过去两年Steris的营收复合增速更高（15.8% vs -6.9%）
伯灵顿百货（前身为伯灵顿大衣厂）是美国知名全国性折扣零售商，在全美46个州及波多黎各拥有超过1138家门店，总部位于新泽西州伯灵顿镇。2007年公司被贝恩资本收购，2008年汤姆·金斯伯里出任总裁兼首席执行官，2013年重新上市，现为美国第三大折扣零售企业。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
BURL vs STE — 直观对比
营收规模更大
BURL
是对方的1.8倍
$1.5B
营收增速更快
STE
高出2.0%
7.1%
净利率更高
STE
高出9.0%
3.9%
自由现金流更多
STE
多$309.1M
$-109.6M
两年增速更快
STE
近两年复合增速
-6.9%
损益表 — Q3 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.7B | $1.5B |
| 净利润 | $104.8M | $192.9M |
| 毛利率 | 44.2% | 43.8% |
| 营业利润率 | 5.1% | 18.3% |
| 净利率 | 3.9% | 12.9% |
| 营收同比 | 7.1% | 9.2% |
| 净利润同比 | 15.6% | 11.2% |
| 每股收益（稀释后） | $1.63 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BURLSTE
| Q4 25 | $2.7B | $1.5B | ||
| Q3 25 | $2.7B | $1.5B | ||
| Q2 25 | $2.5B | $1.4B | ||
| Q1 25 | $3.3B | $1.5B | ||
| Q4 24 | $2.5B | $1.4B | ||
| Q3 24 | $2.5B | $1.3B | ||
| Q2 24 | $2.4B | $1.3B | ||
| Q1 24 | $3.1B | $1.1B |
净利润BURLSTE
| Q4 25 | $104.8M | $192.9M | ||
| Q3 25 | $94.2M | $191.9M | ||
| Q2 25 | $100.8M | $177.4M | ||
| Q1 25 | $260.8M | $145.7M | ||
| Q4 24 | $90.6M | $173.5M | ||
| Q3 24 | $73.8M | $150.0M | ||
| Q2 24 | $78.5M | $145.4M | ||
| Q1 24 | $227.5M | $-1.4M |
毛利率BURLSTE
| Q4 25 | 44.2% | 43.8% | ||
| Q3 25 | 43.7% | 44.2% | ||
| Q2 25 | 43.8% | 45.1% | ||
| Q1 25 | 42.9% | 43.3% | ||
| Q4 24 | 43.9% | 44.5% | ||
| Q3 24 | 42.8% | 43.6% | ||
| Q2 24 | 43.5% | 44.7% | ||
| Q1 24 | 42.7% | 40.2% |
营业利润率BURLSTE
| Q4 25 | 5.1% | 18.3% | ||
| Q3 25 | 4.7% | 18.2% | ||
| Q2 25 | 5.3% | 17.7% | ||
| Q1 25 | 10.6% | 14.6% | ||
| Q4 24 | 4.7% | 17.9% | ||
| Q3 24 | 4.0% | 16.5% | ||
| Q2 24 | 4.7% | 14.5% | ||
| Q1 24 | 10.0% | 22.0% |
净利率BURLSTE
| Q4 25 | 3.9% | 12.9% | ||
| Q3 25 | 3.5% | 13.1% | ||
| Q2 25 | 4.0% | 12.8% | ||
| Q1 25 | 8.0% | 9.8% | ||
| Q4 24 | 3.6% | 12.7% | ||
| Q3 24 | 3.0% | 11.3% | ||
| Q2 24 | 3.3% | 11.4% | ||
| Q1 24 | 7.3% | -0.1% |
每股收益（稀释后）BURLSTE
| Q4 25 | $1.63 | $1.96 | ||
| Q3 25 | $1.47 | $1.94 | ||
| Q2 25 | $1.58 | $1.79 | ||
| Q1 25 | $4.03 | $1.48 | ||
| Q4 24 | $1.40 | $1.75 | ||
| Q3 24 | $1.15 | $1.51 | ||
| Q2 24 | $1.22 | $1.46 | ||
| Q1 24 | $3.51 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $584.1M | $423.7M |
| 总债务越低越好 | $2.0B | $1.9B |
| 股东权益账面价值 | $1.5B | $7.2B |
| 总资产 | $9.6B | $10.6B |
| 负债/权益比越低杠杆越低 | 1.32× | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资BURLSTE
| Q4 25 | $584.1M | $423.7M | ||
| Q3 25 | $747.6M | $319.2M | ||
| Q2 25 | $371.1M | $279.7M | ||
| Q1 25 | $994.7M | $171.7M | ||
| Q4 24 | $857.8M | $155.2M | ||
| Q3 24 | $659.9M | $172.2M | ||
| Q2 24 | $742.3M | $198.3M | ||
| Q1 24 | $925.4M | $207.0M |
总债务BURLSTE
| Q4 25 | $2.0B | $1.9B | ||
| Q3 25 | $2.0B | $1.9B | ||
| Q2 25 | $1.6B | $1.9B | ||
| Q1 25 | $1.5B | $1.9B | ||
| Q4 24 | $1.5B | $2.0B | ||
| Q3 24 | $1.2B | $2.2B | ||
| Q2 24 | $1.2B | $2.2B | ||
| Q1 24 | $1.4B | $3.1B |
股东权益BURLSTE
| Q4 25 | $1.5B | $7.2B | ||
| Q3 25 | $1.4B | $7.0B | ||
| Q2 25 | $1.4B | $7.0B | ||
| Q1 25 | $1.4B | $6.6B | ||
| Q4 24 | $1.1B | $6.4B | ||
| Q3 24 | $1.1B | $6.6B | ||
| Q2 24 | $1.0B | $6.4B | ||
| Q1 24 | $996.9M | $6.3B |
总资产BURLSTE
| Q4 25 | $9.6B | $10.6B | ||
| Q3 25 | $9.3B | $10.4B | ||
| Q2 25 | $8.5B | $10.4B | ||
| Q1 25 | $8.8B | $10.1B | ||
| Q4 24 | $8.4B | $10.0B | ||
| Q3 24 | $7.8B | $10.2B | ||
| Q2 24 | $7.7B | $10.1B | ||
| Q1 24 | $7.7B | $11.1B |
负债/权益比BURLSTE
| Q4 25 | 1.32× | 0.27× | ||
| Q3 25 | 1.40× | 0.27× | ||
| Q2 25 | 1.21× | 0.27× | ||
| Q1 25 | 1.12× | 0.29× | ||
| Q4 24 | 1.35× | 0.32× | ||
| Q3 24 | 1.15× | 0.33× | ||
| Q2 24 | 1.20× | 0.35× | ||
| Q1 24 | 1.40× | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $143.3M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | $-109.6M | $199.5M |
| 自由现金流率自由现金流/营收 | -4.1% | 13.3% |
| 资本支出强度资本支出/营收 | 9.3% | 6.6% |
| 现金转化率经营现金流/净利润 | 1.37× | 1.55× |
| 过去12个月自由现金流最近4个季度 | $-358.5M | $917.1M |
8季度趋势，按日历期对齐
经营现金流BURLSTE
| Q4 25 | $143.3M | $298.2M | ||
| Q3 25 | $179.4M | $287.8M | ||
| Q2 25 | $-28.9M | $420.0M | ||
| Q1 25 | $543.2M | $260.8M | ||
| Q4 24 | $110.4M | $332.8M | ||
| Q3 24 | $160.4M | $250.7M | ||
| Q2 24 | $49.4M | $303.7M | ||
| Q1 24 | $598.5M | $254.8M |
自由现金流BURLSTE
| Q4 25 | $-109.6M | $199.5M | ||
| Q3 25 | $-101.0K | $201.3M | ||
| Q2 25 | $-438.6M | $326.4M | ||
| Q1 25 | $189.8M | $189.9M | ||
| Q4 24 | $-56.2M | $243.6M | ||
| Q3 24 | $-35.2M | $148.8M | ||
| Q2 24 | $-115.5M | $195.7M | ||
| Q1 24 | $410.3M | $163.3M |
自由现金流率BURLSTE
| Q4 25 | -4.1% | 13.3% | ||
| Q3 25 | -0.0% | 13.8% | ||
| Q2 25 | -17.5% | 23.5% | ||
| Q1 25 | 5.8% | 12.8% | ||
| Q4 24 | -2.2% | 17.8% | ||
| Q3 24 | -1.4% | 11.2% | ||
| Q2 24 | -4.9% | 15.3% | ||
| Q1 24 | 13.1% | 14.6% |
资本支出强度BURLSTE
| Q4 25 | 9.3% | 6.6% | ||
| Q3 25 | 6.6% | 5.9% | ||
| Q2 25 | 16.4% | 6.7% | ||
| Q1 25 | 10.8% | 4.8% | ||
| Q4 24 | 6.6% | 6.5% | ||
| Q3 24 | 7.9% | 7.7% | ||
| Q2 24 | 7.0% | 8.4% | ||
| Q1 24 | 6.0% | 8.2% |
现金转化率BURLSTE
| Q4 25 | 1.37× | 1.55× | ||
| Q3 25 | 1.91× | 1.50× | ||
| Q2 25 | -0.29× | 2.37× | ||
| Q1 25 | 2.08× | 1.79× | ||
| Q4 24 | 1.22× | 1.92× | ||
| Q3 24 | 2.18× | 1.67× | ||
| Q2 24 | 0.63× | 2.09× | ||
| Q1 24 | 2.63× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BURL
暂无分部数据
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
